123 related articles for article (PubMed ID: 3161958)
1. [Flow cytometric study on the action of progestogen in patients with adenocarcinoma and precancerous lesions of the endometrium].
Nishiya I; Izutsu T; Satoh K; Yoshizumi N; Kurokawa Y; Kagabu T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1161-8. PubMed ID: 3161958
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of DNA synthetic cells in endometrial carcinoma cases treated with progestogen].
Izutsu T; Fukushima A; Kagabu T; Nishiya I
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Oct; 44(10):1227-32. PubMed ID: 1431435
[TBL] [Abstract][Full Text] [Related]
3. [Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer].
Thurzó L
Zentralbl Gynakol; 1990; 112(17):1111-5. PubMed ID: 2148245
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and histological studies of endometrial carcinoma of the uterus treated with medroxy-progesterone-acetate (author's transl)].
Ohta M; Takeda A; Ninagawa T; Tomoda Y
Nihon Gan Chiryo Gakkai Shi; 1980 Dec; 15(7):1098-103. PubMed ID: 6453176
[No Abstract] [Full Text] [Related]
5. [Adjuvant gestagen therapy in stage I endometrial cancer].
Lahousen M; Pickel H
Zentralbl Gynakol; 1988; 110(16):1013-7. PubMed ID: 2973195
[TBL] [Abstract][Full Text] [Related]
6. [Progesterone receptors in endometrial carcinoma and their response to medroxyprogesterone acetate].
Feng YJ; Zhang XY
Zhonghua Fu Chan Ke Za Zhi; 1989 May; 24(3):153-5, 189. PubMed ID: 2530067
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of advanced endometrial cancer].
Okada H; Yamamoto T
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1848-55. PubMed ID: 2144105
[TBL] [Abstract][Full Text] [Related]
8. DNA ploidy analysis of endometrial adenocarcinoma using a flow cytometry from paraffin-embedded tissues.
Takahashi Y
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Oct; 42(10):1339-44. PubMed ID: 1700035
[TBL] [Abstract][Full Text] [Related]
9. DNA and nuclear protein measurement in columnar epithelial cells of human endometrium.
Oud PS; Reubsaet-Veldhuizen JA; Beck HL; Pahlplatz MM; Hesselmans GH; Hermkens HG; Tas J; James J; Vooijs GP
Cytometry; 1986 Jul; 7(4):325-30. PubMed ID: 2426061
[TBL] [Abstract][Full Text] [Related]
10. [Combination with medroxyprogesterone acetate and chemotherapy making possible complete removal of uterine corpus carcinoma].
Tajima H; Okada T; Fujimori Y; Tomioka Y; Hirano M; Yoshida T; Ikeda S; Hata T
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2461-4. PubMed ID: 2526620
[TBL] [Abstract][Full Text] [Related]
11. [Estrogen and progesterone receptors in endometrial carcinoma during high-dose progestogen (Depo-Provera) therapy].
Thurzó L; Sas M; Falkay G
Orv Hetil; 1986 Oct; 127(43):2613-6. PubMed ID: 2947029
[No Abstract] [Full Text] [Related]
12. Flow cytometrical DNA measurements in endometrial hyperplasias. A prospective follow-up study after abrasio only or additional high-dose gestagen treatment.
Lindahl B; Alm P
Anticancer Res; 1991; 11(1):391-5. PubMed ID: 1826822
[TBL] [Abstract][Full Text] [Related]
13. [Conservative organ-preserving measures in precancerous stages of endometrial cancer].
Dallenbach-Hellweg G
Gynakologe; 1988 Dec; 21(4):302-7. PubMed ID: 2974824
[No Abstract] [Full Text] [Related]
14. Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins.
Gong Y; Anzai Y; Murphy LC; Ballejo G; Holinka CF; Gurpide E; Murphy LJ
Cancer Res; 1991 Oct; 51(20):5476-81. PubMed ID: 1833051
[TBL] [Abstract][Full Text] [Related]
15. Persistence of endometrial activity after radiation therapy for cervical carcinoma.
Barnhill D; Heller P; Dames J; Hoskins W; Gallup D; Park R
Obstet Gynecol; 1985 Dec; 66(6):805-8. PubMed ID: 2999661
[TBL] [Abstract][Full Text] [Related]
16. [Effect of medroxyprogesterone acetate on the cell kinetics in primary breast cancer].
Doihara H; Takashima S; Saeki H; Takiyama W; Kurita A; Soga H; Tanada M; Yokoyama N; Moriwaki S
Gan To Kagaku Ryoho; 1990 Oct; 17(10):2057-62. PubMed ID: 2145805
[TBL] [Abstract][Full Text] [Related]
17. [Effect of treatment with oral 6-methyl-17-hydroxyprogesterone acetate in endometrial adenocarcinoma. Histochemical and ultrastructural aspects].
Vecchietti G; Gerzeli G; Zanoio L; Novelli GG; Barni S; Patton R
Minerva Ginecol; 1981 Apr; 33(4):293-306. PubMed ID: 7243070
[No Abstract] [Full Text] [Related]
18. [Simultaneous cytofluorometric studies on DNA and protein in endometrial adenocarcinoma--with reference to gestagen treatment].
Ohta T
Nihon Sanka Fujinka Gakkai Zasshi; 1986 May; 38(5):750-8. PubMed ID: 3722954
[TBL] [Abstract][Full Text] [Related]
19. Treatment of advanced adenocarcinoma of the endometrium with melphalan, 5-fluorouracil, and medroxyprogesterone acetate: a preliminary study.
Cohen CJ; Deppe G; Bruckner HW
Obstet Gynecol; 1977 Oct; 50(4):415-7. PubMed ID: 904803
[TBL] [Abstract][Full Text] [Related]
20. [Effects of medroxyprogesterone (MAP) therapy on the DNA content in adenocarcinoma of the human endometrium].
Vecchietti G; Gerzeli G; Zanoio L; Novelli GG; Barni S
Minerva Ginecol; 1979; 31(7-8):597-603. PubMed ID: 481819
[No Abstract] [Full Text] [Related]
[Next] [New Search]
